WELLINGTON MANAGEMENT CO LLP 13D and 13G filings for G1 Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-03 1:33 pm Sale |
2020-12-31 | 13G | G1 Therapeutics, Inc. GTHX |
WELLINGTON MANAGEMENT CO LLP | 1,237,342 3.250% |
-1,719,213 (-58.15%) |
Filing |
| 2020-09-09 09:10 am Sale |
2020-08-31 | 13G | G1 Therapeutics, Inc. GTHX |
WELLINGTON MANAGEMENT CO LLP | 2,956,555 7.780% |
-2,211,629 (-42.79%) |
Filing |